GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nicotinamide-nucleotide adenylyltransferase (Q9UYD4)

Analyse AlphaFold monomer V2.0 prediction for nicotinamide-nucleotide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q9UYD4
Type
protein
Length
186 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x461648775Eca78dA7a98b9488A0e39e25b483D17
Molecule
Nicotinamide-nucleotide adenylyltransferase
UniProt
Q9UYD4
Pockets
1 · best druggability 0.63

Structure

1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide-nucleotide adenylyltransferaseprotein18646% helix, 14% strandQ9UYD4

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13640.630.7835empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.